141 related articles for article (PubMed ID: 20686473)
21. First case report of adalimumab-induced psoriasis in Crohn's disease.
Harris MD; Richards R
Am J Gastroenterol; 2009 Mar; 104(3):792-3. PubMed ID: 19262532
[No Abstract] [Full Text] [Related]
22. Prospective evaluation of anti-tumor necrosis factor therapy guided by magnetic resonance imaging for Crohn's perineal fistulas.
Ng SC; Plamondon S; Gupta A; Burling D; Swatton A; Vaizey CJ; Kamm MA
Am J Gastroenterol; 2009 Dec; 104(12):2973-86. PubMed ID: 19755971
[TBL] [Abstract][Full Text] [Related]
23. [Adalimumab for the treatment of Crohn's disease - consensus paper of the Working Group "chronic inflammatory bowel diseases" of the Austrian Society for Gastroenterology and Hepatology].
Reinisch W; Haas T; Kaser A; Petritsch W; Vogelsang H; Feichtenschlager T; Novacek G; Siebert F; Tilg H; Knoflach P
Z Gastroenterol; 2009 Apr; 47(4):372-80. PubMed ID: 19358065
[TBL] [Abstract][Full Text] [Related]
24. [Drug therapy of Crohn disease].
Niemelä S
Duodecim; 2001; 117(8):807-14. PubMed ID: 12116446
[No Abstract] [Full Text] [Related]
25. Editorial: Imaging and the treatment of Crohn's perianal fistulas: to see is to believe.
Schwartz DA
Am J Gastroenterol; 2009 Dec; 104(12):2987-9. PubMed ID: 19956118
[TBL] [Abstract][Full Text] [Related]
26. Adalimumab for recurrent orbital myositis in Crohn's disease: report of a case with a 3-year follow-up.
Hernández-Garfella ML; Gracia-García A; Cervera-Taulet E; García-Villanueva C; Montero-Hernández J
J Crohns Colitis; 2011 Jun; 5(3):265-6. PubMed ID: 21575896
[No Abstract] [Full Text] [Related]
27. Review article: Medical therapy for fistulizing Crohn's disease.
Bressler B; Sands BE
Aliment Pharmacol Ther; 2006 Nov; 24(9):1283-93. PubMed ID: 17059510
[TBL] [Abstract][Full Text] [Related]
28. Fibrotic strictures and anti-TNF-alpha therapy in Crohn's disease.
Sorrentino D; Terrosu G; Vadalà S; Avellini C
Digestion; 2007; 75(1):22-4. PubMed ID: 17429204
[No Abstract] [Full Text] [Related]
29. [New therapy in inflammatory bowel disease (infliximab)].
Yoshizawa S; Hibi T
Nihon Rinsho; 2008 Jul; 66(7):1279-85. PubMed ID: 18616118
[TBL] [Abstract][Full Text] [Related]
30. Oropharyngeal and proximal esophageal involvement during adalimumab treatment of Crohn disease.
Nguyen KD; Alexis R; Schwarz SM
J Pediatr Gastroenterol Nutr; 2010 Feb; 50(2):225-6. PubMed ID: 19841594
[No Abstract] [Full Text] [Related]
31. [What is your diagnosis? Bilateral dacryoadenitis].
Dielmann K; Zeier M
Dtsch Med Wochenschr; 2007 Sep; 132(36):1827-8. PubMed ID: 17726654
[No Abstract] [Full Text] [Related]
32. [Top-down versus Step-Up: new strategies in the treatment of Crohn's disease].
Meier J; Sturm A
Z Gastroenterol; 2009 Feb; 47(2):240-2. PubMed ID: 19197829
[No Abstract] [Full Text] [Related]
33. Vaccinating patients with inflammatory bowel disease--primum non nocere.
Muhammad R; Wong CL; Limdi JK
Scand J Gastroenterol; 2012 Sep; 47(8-9):1122-3. PubMed ID: 22554229
[No Abstract] [Full Text] [Related]
34. Metastatic Crohn's disease: a diagnostic and therapeutic challenge.
Lang N; Hartschuh W; Enk A; Toberer F
J Dtsch Dermatol Ges; 2015 Jun; 13(6):571-4. PubMed ID: 26018372
[No Abstract] [Full Text] [Related]
35. Treatment of recurrent Crohn's uveitis with infliximab.
Ally MR; Veerappan GR; Koff JM
Am J Gastroenterol; 2008 Aug; 103(8):2150-1. PubMed ID: 18796120
[No Abstract] [Full Text] [Related]
36. Infliximab in the management of the extra-intestinal manifestations of Crohn's disease.
Lawrance IC
J Gastroenterol Hepatol; 2004 Nov; 19(11):1332-3. PubMed ID: 15482549
[No Abstract] [Full Text] [Related]
37. Distal esophageal involvement in Crohn disease: short treatment with adalimumab.
Musto D; Martorelli L; Cirillo A; Selvaggi F; Esposito P; Russo MI; Riegler G
Endoscopy; 2010; 42 Suppl 2():E299. PubMed ID: 21113880
[No Abstract] [Full Text] [Related]
38. Acute dacryoadenitis and Crohn's disease: findings and management.
Dutt S; Cartwright MJ; Nelson CC
Ophthalmic Plast Reconstr Surg; 1992; 8(4):295-9. PubMed ID: 1476981
[TBL] [Abstract][Full Text] [Related]
39. Rapid recovery of a rectovaginal fistula with infliximab in a patient with Crohn's disease.
Hagiu C; Badea R; Serban A; Petrar S; Andreica V
J Gastrointestin Liver Dis; 2010 Sep; 19(3):329-32. PubMed ID: 20922201
[TBL] [Abstract][Full Text] [Related]
40. The Italian Society of Gastroenterology (SIGE) and the Italian Group for the study of Inflammatory Bowel Disease (IG-IBD) Clinical Practice Guidelines: The use of tumor necrosis factor-alpha antagonist therapy in inflammatory bowel disease.
Orlando A; Armuzzi A; Papi C; Annese V; Ardizzone S; Biancone L; Bortoli A; Castiglione F; D'Incà R; Gionchetti P; Kohn A; Poggioli G; Rizzello F; Vecchi M; Cottone M; ;
Dig Liver Dis; 2011 Jan; 43(1):1-20. PubMed ID: 20843756
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
